Journal Articles Published In 2025
2775998
TCMBXKKM
2025
1
padagogische-hochschule-bern-institut-vorschulstufe-und-primarstufe
50
date
desc
year
4794
https://www.iedea-sa.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22HXCBRY88%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Schwab%20et%20al.%22%2C%22parsedDate%22%3A%222025-03-12%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ESchwab%2C%20Tiana%20C.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EJoseph%2C%20Lavania%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EMoono%2C%20Andrew%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EG%26%23xF6%3Bller%2C%20Pauline%20C.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EMotsei%2C%20Mamello%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282025%29.%20Field%20evaluation%20of%20nanopore%20targeted%20next-generation%20sequencing%20to%20predict%20drug-resistant%20tuberculosis%20from%20native%20sputum%20in%20South%20Africa%20and%20Zambia.%20%3Ci%3EJournal%20of%20Clinical%20Microbiology%3C%5C%2Fi%3E%2C%20%3Ci%3E63%3C%5C%2Fi%3E%20%283%29%2C%20S.%20e0139024.%20%3Ca%20class%3D%27zp-DOIURL%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2Fjcm.01390-24%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2Fjcm.01390-24%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Field%20evaluation%20of%20nanopore%20targeted%20next-generation%20sequencing%20to%20predict%20drug-resistant%20tuberculosis%20from%20native%20sputum%20in%20South%20Africa%20and%20Zambia%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tiana%20C.%22%2C%22lastName%22%3A%22Schwab%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lavania%22%2C%22lastName%22%3A%22Joseph%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Moono%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pauline%20C.%22%2C%22lastName%22%3A%22G%5Cu00f6ller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mamello%22%2C%22lastName%22%3A%22Motsei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guy%22%2C%22lastName%22%3A%22Muula%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denise%22%2C%22lastName%22%3A%22Evans%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefan%22%2C%22lastName%22%3A%22Neuenschwander%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gunar%22%2C%22lastName%22%3A%22G%5Cu00fcnther%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carolyn%22%2C%22lastName%22%3A%22Bolton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20M.%22%2C%22lastName%22%3A%22Keller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alban%22%2C%22lastName%22%3A%22Ramette%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Egger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shaheed%20V.%22%2C%22lastName%22%3A%22Omar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lukas%22%2C%22lastName%22%3A%22Fenner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22IeDEA%20Southern%20Africa%20%28IeDEA-SA%29%22%7D%5D%2C%22abstractNote%22%3A%22Rapid%20and%20comprehensive%20drug%20susceptibility%20testing%20%28DST%29%20is%20essential%20for%20diagnosing%20and%20treating%20drug-resistant%20tuberculosis%20effectively%2C%20and%20next-generation%20sequencing%20can%20be%20an%20effective%20genotypic%20DST%20method.%20We%20implemented%20and%20evaluated%20the%20performance%20of%20a%20nanopore%20targeted%20sequencing%20assay%2C%20called%20the%20Tuberculosis%20Drug%20Resistance%20Test%20%28TBDR%2C%20Oxford%20Nanopore%20Diagnostics%2C%20Ltd.%2C%20United%20Kingdom%29%2C%20which%20predicts%20drug%20resistance%20to%2016%20TB%20drugs%2C%20at%20a%20South%20African%20reference%20laboratory%20and%20a%20district%20diagnostic%20laboratory%20in%20Zambia.%20We%20compared%20the%20sequencing%20success%20rates%20between%20unprocessed%20and%20decontaminated%20sputum%20samples%20and%20determined%20the%20diagnostic%20accuracy%20against%20local%20DST%20%28Xpert%20MTB%5C%2FRIF%20Ultra%2C%20Xpert%20MTB%5C%2FXDR%2C%20and%20BD%20BACTEC%20MGIT%20phenotypic%20DST%29.%20We%20prospectively%20sequenced%20236%20samples%20and%20have%20148%20samples%20with%20sequencing%20results%20from%20unprocessed%20and%20decontaminated%20sputum.%20We%20obtained%20successful%20sequencing%20results%20from%2066.4%25%20%2894%5C%2F148%29%20unprocessed%20sputum%20samples%20and%2075%25%20%28111%5C%2F148%29%20decontaminated%20samples.%20Sequencing%20success%20rates%20at%20the%20two%20sites%20differed%2C%20with%2050.7%25%20%2836%5C%2F71%29%20successful%20sequencing%20results%20from%20unprocessed%20sputum%20in%20Zambia%20and%2075.3%25%20%2858%5C%2F77%29%20in%20South%20Africa.%20Samples%20with%20%5C%22low%5C%22%20bacterial%20load%2C%20measured%20by%20Xpert%20MTB%5C%2FRIF%20Ultra%2C%20tended%20to%20produce%20fewer%20successful%20sequencing%20results.%20TBDR%20sequencing%20predicted%20resistances%20in%2048%20samples%2C%20detecting%20resistance%20for%20rifampicin%20%28n%20%3D%2041%29%20and%20isoniazid%20%28n%20%3D%2020%29%2C%20as%20well%20as%2010%20second-line%20drugs%20%28n%20%3D%2015%29.%20Sensitivity%20was%20variable%20compared%20to%20phenotypic%20DST%2C%20ranging%20from%2033%20%28ethionamide%29%20to%2094%25%20%28rifampicin%29%2C%20while%20specificity%20remained%20above%2090%25%20for%20all%20drugs%2C%20except%20clofazimine.%20The%20TBDR%20assay%20can%20provide%20rapid%2C%20comprehensive%20genotypic%20DST.%20Technical%20and%20operational%20challenges%20need%20to%20be%20addressed%20for%20its%20broader%20implementation%20in%20high%20tuberculosis-burden%20settings.IMPORTANCEThis%20study%20illustrates%20the%20use%20of%20the%20Tuberculosis%20Drug%20Resistance%20Test%20%28TBDR%2C%20Oxford%20Nanopore%20Diagnostics%2C%20Ltd.%2C%20United%20Kingdom%29%20as%20a%20rapid%20drug%20susceptibility%20testing%20%28DST%29%20approach%20for%20diagnosing%20drug-resistant%20TB%20in%20the%20high%20TB-burden%20countries%20of%20South%20Africa%20and%20Zambia.%20The%20TBDR%20assay%20predicts%20resistance%20to%2016%20TB%20drugs%2C%20including%20first-%20and%20second-line%20treatments.%20By%20implementing%20the%20TBDR%20assay%20in%20a%20national%20reference%20laboratory%20in%20South%20Africa%20and%20a%20district%20diagnostic%20laboratory%20in%20Zambia%2C%20we%20demonstrate%20how%20this%20technology%20can%20provide%20faster%20diagnostic%20results%20%28days%29%20compared%20to%20traditional%20phenotypic%20DST%20methods%20%28~2%20months%29%2C%20with%20adequate%20sensitivity.%20Missed%20resistances%20compared%20to%20phenotypic%20DST%20indicate%20that%20technical%20improvements%20are%20needed.%20Successful%20sequencing%20from%20unprocessed%20and%20decontaminated%20sputum%20samples%20at%20different%20sites%20suggests%20feasibility%20in%20diverse%20settings%2C%20though%20operational%20challenges%20remain.%20Implementing%20this%20rapid%2C%20comprehensive%20DST%20approach%20could%20enhance%20drug-resistant%20tuberculosis%20diagnosis%20and%20treatment%2C%20ultimately%20improving%20patient%20outcomes%20and%20helping%20to%20combat%20tuberculosis%20in%20high-burden%20regions.%22%2C%22date%22%3A%222025-03-12%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1128%5C%2Fjcm.01390-24%22%2C%22ISSN%22%3A%221098-660X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22TCMBXKKM%22%5D%2C%22dateModified%22%3A%222025-03-20T12%3A32%3A48Z%22%7D%7D%2C%7B%22key%22%3A%22FWC57YQB%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Chihota%20et%20al.%22%2C%22parsedDate%22%3A%222025-02-07%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EChihota%2C%20Belinda%20Varaidzo%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EMandiriri%2C%20Ardele%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EMuula%2C%20Guy%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EBanda%2C%20Esau%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EShamu%2C%20Tinei%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282025%29.%20Cohort%20profile%3A%20Noncommunicable%20diseases%20and%20ideal%20cardiovascular%20health%20among%20people%20living%20with%20and%20without%20HIV%20in%20Zambia%20and%20Zimbabwe%20%28NCDzz%20cohort%29.%20%3Ci%3EBMJ%20Open%3C%5C%2Fi%3E%2C%20%3Ci%3E15%3C%5C%2Fi%3E%20%282%29%2C%20S.%20e088706.%20%3Ca%20class%3D%27zp-DOIURL%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmjopen-2024-088706%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmjopen-2024-088706%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Cohort%20profile%3A%20Noncommunicable%20diseases%20and%20ideal%20cardiovascular%20health%20among%20people%20living%20with%20and%20without%20HIV%20in%20Zambia%20and%20Zimbabwe%20%28NCDzz%20cohort%29.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Belinda%20Varaidzo%22%2C%22lastName%22%3A%22Chihota%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ardele%22%2C%22lastName%22%3A%22Mandiriri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guy%22%2C%22lastName%22%3A%22Muula%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Esau%22%2C%22lastName%22%3A%22Banda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tinei%22%2C%22lastName%22%3A%22Shamu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carolyn%22%2C%22lastName%22%3A%22Bolton-Moore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cleophas%22%2C%22lastName%22%3A%22Chimbetete%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samuel%22%2C%22lastName%22%3A%22Bosomprah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gilles%22%2C%22lastName%22%3A%22Wandeler%22%7D%5D%2C%22abstractNote%22%3A%22PURPOSE%3A%20The%20NCDzz%20study%20is%20a%20prospective%20cohort%20of%20people%20living%20with%20and%20without%20HIV%20attending%20primary%20care%20clinics%20in%20Zambia%20and%20Zimbabwe%20and%20was%20established%20in%202019%20to%20understand%20the%20intersection%20between%20noncommunicable%20diseases%20%28NCDs%29%20and%20HIV%20in%20Southern%20Africa.%20Here%2C%20we%20describe%20the%20study%20design%20and%20population%20and%20evaluate%20their%20ideal%20cardiovascular%20health%20%28ICVH%29%20using%20the%20Life%27s%20Simple%207%20%28LS7%29%20score%20according%20to%20the%20American%20Heart%20Association.%20PARTICIPANTS%3A%20Antiretroviral%20therapy-naive%20people%20living%20with%20HIV%20%28PLWH%29%20and%20people%20living%20without%20HIV%20%28PLWOH%29%2030%20years%20or%20older%20were%20recruited%20from%20three%20primary%20care%20clinics%20in%20Lusaka%20and%20Harare%2C%20and%20underwent%20comprehensive%20clinical%2C%20laboratory%20and%20behavioural%20assessments.%20All%20study%20measurements%20are%20repeated%20during%20yearly%20follow-up%20visits.%20PLWOH%20were%20recruited%20from%20the%20same%20neighbourhoods%20and%20had%20similar%20socioeconomic%20conditions%20as%20PLWH.%20FINDINGS%20TO%20DATE%3A%20Between%20August%202019%20and%20March%202023%2C%20we%20included%201100%20adults%2C%20of%20whom%20618%20%2856%25%29%20were%20females%20and%20539%20%2849%25%29%20were%20PLWH.%20The%20median%20age%20at%20enrolment%20was%2039%20years%20%28IQR%2034-46%20years%29.%20Among%201013%20participants%20%2892%25%29%20with%20complete%20data%2C%20the%20median%20LS7%20score%20was%2011%5C%2F14%20%28IQR%2010-12%29.%20Overall%2C%2060%25%20of%20participants%20met%20the%20criteria%20of%20ICVH%20metrics%20%285-7%20ideal%20components%29%20and%20among%20individual%20components%20of%20the%20LS7%2C%20more%20females%20had%20poor%20body%20mass%20index%20%28BMI%29%20than%20males%2C%20regardless%20of%20HIV%20status%20%2827%25%20vs%203%25%2C%20p%3C0.001%29.%20Our%20data%20show%20no%20apparent%20difference%20in%20cardiovascular%20health%20determinants%20between%20men%20and%20women%2C%20but%20high%20BMI%20in%20women%20and%20overall%20high%20hypertension%20prevalence%20need%20detailed%20investigation.%20Untreated%20HIV%20%28OR%3A%201.36%20%28IQR%201.05-1.78%29%29%20and%20being%20a%20Zambian%20participant%20%28OR%3A%201.81%20%28IQR%201.31-2.51%29%29%20were%20associated%20with%20having%20ICVH%20metrics%2C%20whereas%20age%20older%20than%2050%20years%20%28OR%3A%200.46%20%28IQR%200.32-0.65%29%29%20was%20associated%20with%20not%20having%20ICVH%20metrics.%20FUTURE%20PLANS%3A%20Our%20study%20will%20be%20regularly%20updated%20with%20upcoming%20analyses%20using%20prospective%20data%20including%20a%20focus%20on%20arterial%20hypertension%20and%20vascular%20function.%20We%20plan%20to%20enrich%20the%20work%20through%20conducting%20in-depth%20assessments%20on%20the%20determinants%20of%20cardiovascular%2C%20liver%20and%20kidney%20end-organ%20disease%20outcomes%20yearly.%20Additionally%2C%20we%20seek%20to%20pilot%20NCD%20interventions%20using%20novel%20methodologies%20like%20the%20trials%20within%20cohorts.%20Beyond%20the%20initial%20funding%20support%2C%20we%20aim%20to%20collect%20at%20minimum%20yearly%20data%20for%20an%20additional%205-year%20period.%22%2C%22date%22%3A%222025%20Feb%207%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1136%5C%2Fbmjopen-2024-088706%22%2C%22ISSN%22%3A%222044-6055%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22TCMBXKKM%22%5D%2C%22dateModified%22%3A%222025-03-10T15%3A58%3A06Z%22%7D%7D%2C%7B%22key%22%3A%22SCPEDY7T%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Anderson%20et%20al.%22%2C%22parsedDate%22%3A%222025-02%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EAnderson%2C%20Kim%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ERabie%2C%20Helena%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EEley%2C%20Brian%20S.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EFrigati%2C%20Lisa%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ENuttall%2C%20James%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282025%29.%20Mother-child%20dyads%20living%20with%20HIV%20in%20the%20Western%20Cape%2C%20South%20Africa%3A%20Undetectable%20%3D%20Undetectable%3F%20%3Ci%3EJournal%20of%20the%20International%20AIDS%20Society%3C%5C%2Fi%3E%2C%20%3Ci%3E28%3C%5C%2Fi%3E%20%282%29%2C%20S.%20e26418.%20%3Ca%20class%3D%27zp-DOIURL%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26418%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26418%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Mother-child%20dyads%20living%20with%20HIV%20in%20the%20Western%20Cape%2C%20South%20Africa%3A%20Undetectable%20%3D%20Undetectable%3F%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kim%22%2C%22lastName%22%3A%22Anderson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helena%22%2C%22lastName%22%3A%22Rabie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%20S.%22%2C%22lastName%22%3A%22Eley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lisa%22%2C%22lastName%22%3A%22Frigati%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%22%2C%22lastName%22%3A%22Nuttall%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emma%22%2C%22lastName%22%3A%22Kalk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexa%22%2C%22lastName%22%3A%22Heekes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gayathri%22%2C%22lastName%22%3A%22Sridhar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leigh%22%2C%22lastName%22%3A%22Ragone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vani%22%2C%22lastName%22%3A%22Vannappagari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanessa%22%2C%22lastName%22%3A%22Mudaly%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Boulle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary-Ann%22%2C%22lastName%22%3A%22Davies%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Globally%2C%20children%20living%20with%20HIV%20continue%20to%20lag%20behind%20UNAIDS%20targets%20for%20viral%20suppression%20%28VS%29.%20Because%20studies%20with%20linked%20mother-child%20data%20are%20limited%2C%20we%20describe%20VS%20and%20associated%20factors%20among%20young%20children%20in%20a%20setting%20with%20early%20infant%20HIV%20testing%20%28at%20birth%2C%20age%2010%20weeks%20and%206%20months%29%20and%20early%20protease%20inhibitor-based%20first-line%20antiretroviral%20therapy%20%28ART%29.%20METHODS%3A%20We%20analysed%20routinely%20collected%20mother-child%20data%20for%20children%20living%20with%20HIV%20born%202018-2022%20in%20Western%20Cape%20province%2C%20South%20Africa%20%28followed%20through%20mid-2023%29.%20We%20assessed%20associations%20between%20child%20and%20maternal%20viral%20load%20%28VL%29%20results%20at%2012%20and%2024%20months%20after%20child%20ART%20start%20using%20logistic%20regression%2C%20adjusted%20for%20child%20sex%2C%20birthyear%2C%20severity%20of%20child%20immunodeficiency%20at%20ART%20start%2C%20maternal%20age%20and%20timing%20of%20maternal%20HIV%20diagnosis.%20RESULTS%3A%20Among%202219%20children%20living%20with%20HIV%3B%2030%25%20were%20diagnosed%20at%20birth%20%28%3C%5C%2F%3D7%20days%29%2C%2041%25%20before%20age%201%20year%20%288-365%20days%29%20and%2029%25%20at%20age%20%3E1%20year.%20Overall%2C%205%25%20%28n%20%3D%20112%5C%2F2219%29%20of%20children%20died%2C%20a%20third%20of%20whom%20had%20not%20started%20ART%3B%2090%25%20of%20children%20%28n%20%3D%201990%29%20started%20ART%2C%20at%20median%20age%205%20months%20%28IQR%201-16%29.%20Median%20follow-up%20from%20ART%20start%20was%2026%20months%20%28IQR%2014-40%29.%20Among%20children%20with%20available%20VL%20at%2012%20months%20%28n%20%3D%20853%5C%2F1582%29%2C%2024%20months%20%28n%20%3D%20614%5C%2F1129%29%20and%2036%20months%20%28n%20%3D%20350%5C%2F658%29%20after%20ART%20start%2C%2036%25%2C%2043%25%20and%2048%25%20were%20virally%20suppressed%2C%20respectively%20%28VL%3C100%20copies%5C%2Fml%29.%20VS%20among%20children%20at%2012%20and%2024%20months%20was%20more%20likely%20if%20maternal%20VL%20was%20%3C100%20versus%20%3E%5C%2F%3D100%20copies%5C%2Fml%20at%2012%20months%20%28adjusted%20odds%20ratio%20%5BaOR%5D%20%3D%203.5%3B%2095%25%20CI%201.9-6.5%29%20and%2024%20months%20%28aOR%20%3D%206.1%3B%2095%25%20CI%202.8-13.1%29%20after%20child%20ART%20start.%20Children%20with%20no%5C%2Fmild%20versus%20advanced%5C%2Fsevere%20immunodeficiency%20at%20ART%20start%20were%20more%20likely%20to%20achieve%20VS%20at%2012%20months%20%28aOR%20%3D%202.3%3B%2095%25%20CI%201.3-4.2%29%20but%20not%20at%2024%20months.%20Eligible%20children%20with%20missing%20VL%20at%2024%20months%20%2839%25%29%20were%20more%20likely%20to%20have%20gaps%20in%20care%20of%20%3E6%20months%20than%20those%20with%20VL%3E%5C%2F%3D100%20or%20VL%3C100%20copies%5C%2Fml%20%2884%25%20vs.%2028%25%20vs.%2014%25%2C%20respectively%3B%20p%3C0.001%29.%20CONCLUSIONS%3A%20Less%20than%20half%20of%20children%20on%20ART%20achieved%20VS%2C%20and%20children%20were%20more%20likely%20to%20achieve%20VS%20if%20their%20mothers%20were%20also%20virally%20suppressed.%20Significant%20efforts%20are%20needed%20to%20support%20mother-child%20dyads%20to%20achieve%20optimal%20VS.%22%2C%22date%22%3A%222025%20Feb%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.26418%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22TCMBXKKM%22%5D%2C%22dateModified%22%3A%222025-03-10T15%3A58%3A39Z%22%7D%7D%2C%7B%22key%22%3A%227NGNKLUM%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Banholzer%20et%20al.%22%2C%22parsedDate%22%3A%222025-02%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EBanholzer%2C%20Nicolas%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EMiddelkoop%2C%20Keren%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ELeukes%2C%20Juane%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EWeingartner%2C%20Ernest%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ESchmutz%2C%20Remo%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282025%29.%20Estimating%20Mycobacterium%20tuberculosis%20transmission%20in%20a%20South%20African%20clinic%3A%20Spatiotemporal%20model%20based%20on%20person%20movements.%20%3Ci%3EPLoS%20Computational%20Biology%3C%5C%2Fi%3E%2C%20%3Ci%3E21%3C%5C%2Fi%3E%20%282%29%2C%20S.%20e1012823.%20%3Ca%20class%3D%27zp-DOIURL%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pcbi.1012823%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pcbi.1012823%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Estimating%20Mycobacterium%20tuberculosis%20transmission%20in%20a%20South%20African%20clinic%3A%20Spatiotemporal%20model%20based%20on%20person%20movements.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Banholzer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keren%22%2C%22lastName%22%3A%22Middelkoop%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juane%22%2C%22lastName%22%3A%22Leukes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ernest%22%2C%22lastName%22%3A%22Weingartner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Remo%22%2C%22lastName%22%3A%22Schmutz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathrin%22%2C%22lastName%22%3A%22Zurcher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Egger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robin%22%2C%22lastName%22%3A%22Wood%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lukas%22%2C%22lastName%22%3A%22Fenner%22%7D%5D%2C%22abstractNote%22%3A%22The%20risk%20of%20Mycobacterium%20tuberculosis%20%28Mtb%29%20transmission%20can%20be%20high%20in%20crowded%20clinics.%20We%20developed%20a%20spatiotemporal%20model%20of%20airborne%20Mtb%20transmission%20based%20on%20the%20Wells-Riley%20equation.%20We%20collected%20environmental%2C%20clinical%20and%20person-tracking%20data%20in%20a%20South%20African%20clinic%20during%20COVID-19%2C%20when%20community%20or%20surgical%20masks%20were%20compulsory%20and%20ventilation%20was%20increased.%20We%20matched%20person%20movements%20with%20clinical%20records%20to%20identify%20the%20spatiotemporal%20location%20of%20infectious%20TB%20patients.%20We%20modeled%20the%20concentration%20of%20infectious%20doses%20%28quanta%29%20and%20estimated%20the%20individual%20risk%20of%20infection.%20Over%20five%20days%2C%20video%20sensors%20tracked%201%2C438%20clinic%20attendees.%20CO2%20levels%20were%20low%20%28median%20431%20ppm%2C%20IQR%20406%20ppm-458%20ppm%29%3B%20the%20quanta%20concentration%20was%20higher%20in%20the%20morning%20than%20in%20the%20afternoon%2C%20and%20highest%20in%20the%20waiting%20room.%20The%20estimated%20risk%20of%20infection%20per%20clinic%20attendee%20was%200.05%25%20%2880%25-credible%20interval%20%28CrI%29%200.01%25-0.06%25%29.%20It%20increased%20with%20the%20number%20of%20close%20contacts%20with%20infectious%20patients%20and%20the%20time%20spent%20in%20the%20clinic%2C%20and%20was%201.3-fold%20%2895%25-CrI%201.2-1.4%29%20higher%20in%20scenarios%20without%20mask%20use%20and%202.1-fold%20%2895%25-CrI%200.9-5.0%29%20higher%20with%20pre-pandemic%20ventilation%20rates%2C%20emphasizing%20the%20importance%20of%20ventilation.%20Spatiotemporal%20modeling%20can%20identify%20high-%20risk%20areas%20and%20evaluate%20the%20impact%20of%20infection%20control%20measures%20in%20clinics.%22%2C%22date%22%3A%222025%20Feb%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pcbi.1012823%22%2C%22ISSN%22%3A%221553-7358%201553-734X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22TCMBXKKM%22%5D%2C%22dateModified%22%3A%222025-03-10T15%3A58%3A26Z%22%7D%7D%2C%7B%22key%22%3A%224H6RFYTE%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ford%20et%20al.%22%2C%22parsedDate%22%3A%222025-02%22%2C%22numChildren%22%3A7%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EFord%2C%20Nathan%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EKassanjee%2C%20Reshma%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EStelzle%2C%20Dominik%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EJarvis%2C%20Joseph%20N.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ESued%2C%20Omar%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282025%29.%20Global%20prevalence%20of%20advanced%20HIV%20disease%20in%20healthcare%20settings%3A%20a%20rapid%20review.%20%3Ci%3EJournal%20of%20the%20International%20AIDS%20Society%3C%5C%2Fi%3E%2C%20%3Ci%3E28%3C%5C%2Fi%3E%20%282%29%2C%20S.%20e26415.%20%3Ca%20class%3D%27zp-DOIURL%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26415%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26415%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Global%20prevalence%20of%20advanced%20HIV%20disease%20in%20healthcare%20settings%3A%20a%20rapid%20review.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathan%22%2C%22lastName%22%3A%22Ford%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reshma%22%2C%22lastName%22%3A%22Kassanjee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dominik%22%2C%22lastName%22%3A%22Stelzle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20N.%22%2C%22lastName%22%3A%22Jarvis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Omar%22%2C%22lastName%22%3A%22Sued%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Georges%22%2C%22lastName%22%3A%22Perrin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meg%22%2C%22lastName%22%3A%22Doherty%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajay%22%2C%22lastName%22%3A%22Rangaraj%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Recent%20studies%20have%20indicated%20a%20high%20enduring%20burden%20of%20advanced%20HIV%20disease%2C%20but%20estimates%20across%20regions%20and%20settings%20are%20lacking.%20The%20aim%20of%20this%20study%20was%20to%20estimate%20the%20prevalence%20of%20advanced%20HIV%20disease%20since%202015%20among%20those%20people%20with%20CD4%20measured%20in%20healthcare%20settings%2C%20disaggregated%20by%20age%20group%2C%20level%20of%20healthcare%20and%20region.%20METHODS%3A%20We%20searched%20MedLine%20via%20Pubmed%20and%20Hinari%20for%20studies%20that%20reported%20the%20proportion%20of%20individuals%20with%20advanced%20HIV%20disease%20%28defined%20as%20CD4%20cell%20count%20%3C200%20cells%5C%2Fmm%283%29%29%20in%20healthcare%20settings%20since%202015%3B%20this%20search%20was%20complemented%20by%20conference%20abstracts%20and%20data%20from%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20Consortium%20%28IeDEA%29.%20We%20estimated%20pooled%20prevalence%20of%20advanced%20HIV%20disease%20using%20random-%20effects%20models%20and%20performed%20subgroup%20and%20sensitivity%20analyses%20to%20explore%20heterogeneity.%20RESULTS%3A%20We%20obtained%20data%20from%20117%20cohorts%2C%20representing%201%2C814%2C362%20individuals%20from%2052%20countries%20across%20all%20six%20World%20Health%20Organization%20regions.%20The%20majority%20of%20studies%20%28n%20%3D%2083%29%20were%20conducted%20among%20adults%20and%20recorded%20CD4%20cell%20count%20among%20treatment%20naive%20individuals%20at%20antiretroviral%20therapy%20start%20%28n%20%3D%2086%29.%20Studies%20included%20data%20reported%20up%20to%202023.%20The%20proportion%20of%20individuals%20with%20advanced%20HIV%20disease%20was%20higher%20in%20inpatient%20settings%20%2844.3%25%2C%2095%25%20CI%2039.1-49.6%25%29%20compared%20to%20outpatient%20settings%20%2833.5%25%2C%2095%25%20CI%2031.5-35.4%25%29.%20Prevalence%20was%20similar%20across%20age%20groups%2C%20time%20since%20HIV%20diagnosis%20and%20treatment%20status%2C%20and%20highest%20in%20West%20and%20Central%20Africa%2C%20South-East%20Asia%20and%20the%20Eastern%20Mediterranean%20region.%20DISCUSSION%3A%20This%20review%20finds%20that%20at%20least%20a%20third%20of%20people%20presenting%20to%20healthcare%20settings%20have%20advanced%20HIV%20disease%2C%20with%20no%20evidence%20that%20this%20has%20changed%20in%20recent%20years.%20Screening%20for%20advanced%20HIV%20remains%20important%20to%20be%20able%20to%20direct%20appropriate%20preventive%2C%20diagnostic%20and%20therapeutic%20interventions%20to%20prevent%20progression%20to%20severe%20illness%20and%20death.%20CONCLUSIONS%3A%20This%20review%20summarizes%20recent%20evidence%20of%20the%20continued%20high%20proportion%20of%20individuals%20who%20%28re%29present%20to%20care%20with%20advanced%20HIV%20disease.%20These%20findings%20underscore%20the%20urgent%20need%20to%20reinforce%20programme%20capacity%20to%20diagnose%2C%20prevent%20and%20treat%20advanced%20HIV%20disease%20as%20an%20essential%20pillar%20of%20the%20global%20AIDS%20response.%22%2C%22date%22%3A%222025%20Feb%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.26415%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22369YB7BV%22%2C%22NMNPNZRP%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%22YAE5EUBI%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222025-03-10T15%3A54%3A23Z%22%7D%7D%2C%7B%22key%22%3A%22LQ46ZRQH%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Didden%20et%20al.%22%2C%22parsedDate%22%3A%222025-01-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EDidden%2C%20Christiane%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EEgger%2C%20Matthias%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EFolb%2C%20Naomi%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EMaartens%2C%20Gary%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ERohner%2C%20Eliane%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282025%29.%20The%20Contribution%20of%20Noncommunicable%20and%20Infectious%20Diseases%20to%20the%20Effect%20of%20Depression%20on%20Mortality%3A%20A%20Longitudinal%20Causal%20Mediation%20Analysis.%20%3Ci%3EEpidemiology%20%28Cambridge%2C%20Mass.%29%3C%5C%2Fi%3E%2C%20%3Ci%3E36%3C%5C%2Fi%3E%20%281%29%2C%20S.%2088%26%23x2013%3B98.%20%3Ca%20class%3D%27zp-DOIURL%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FEDE.0000000000001804%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FEDE.0000000000001804%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20Contribution%20of%20Noncommunicable%20and%20Infectious%20Diseases%20to%20the%20Effect%20of%20Depression%20on%20Mortality%3A%20A%20Longitudinal%20Causal%20Mediation%20Analysis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christiane%22%2C%22lastName%22%3A%22Didden%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Egger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Naomi%22%2C%22lastName%22%3A%22Folb%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gary%22%2C%22lastName%22%3A%22Maartens%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eliane%22%2C%22lastName%22%3A%22Rohner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reshma%22%2C%22lastName%22%3A%22Kassanjee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cristina%22%2C%22lastName%22%3A%22Mesa-Vieira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ayesha%22%2C%22lastName%22%3A%22Kriel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Soraya%22%2C%22lastName%22%3A%22Seedat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andreas%20D.%22%2C%22lastName%22%3A%22Haas%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20The%20increased%20prevalence%20of%20physical%20diseases%20among%20individuals%20with%20mental%20illness%20contributes%20to%20their%20increased%20risk%20of%20mortality.%20However%2C%20the%20mediating%20role%20of%20specific%20diseases%20in%20the%20effect%20of%20mental%20illness%20on%20mortality%20is%20not%20well%20understood.%5CnMETHOD%3A%20We%20conducted%20a%20longitudinal%20causal%20mediation%20analysis%20using%20data%20from%20beneficiaries%20of%20a%20South%20African%20medical%20insurance%20scheme%20from%202011%20to%202020.%20We%20estimated%20the%20overall%20effect%20of%20major%20depressive%20disorder%20%28MDD%29%20on%20mortality%20and%20evaluated%20reductions%20in%20this%20overall%20effect%20through%20hypothetical%20interventions%20on%20the%20risks%20of%20mediating%20physical%20diseases%20using%20an%20interventional%20effects%20approach.%20Monte%20Carlo%20simulation-based%20g-computation%20was%20used%20for%20estimation.%5CnRESULTS%3A%20Among%20981%2C540%20individuals%2C%20143%2C314%20%2814.6%25%29%20were%20diagnosed%20with%20MDD.%20Mortality%20risk%20after%208%20years%20was%206.5%25%20under%20MDD%2C%20and%205.3%25%20under%20no%20MDD%20%28risk%20ratio%201.23%2C%2095%25%20CI%20%3D%201.19%2C%201.26%29.%20Overall%2C%2043.4%25%20of%20this%20disparity%20could%20be%20attributed%20to%20higher%20rates%20of%20physical%20comorbidities%20due%20to%20MDD.%20Cardiovascular%20diseases%20accounted%20for%2017.8%25%2C%20followed%20by%20chronic%20respiratory%20diseases%20%288.6%25%29%2C%20cancers%20%287.5%25%29%2C%20diabetes%20and%20chronic%20kidney%20disease%20%285.8%25%29%2C%20tuberculosis%20%284.3%25%29%2C%20and%20HIV%20%282.7%25%29.%5CnCONCLUSION%3A%20Within%20the%20privately%20insured%20population%20of%20South%20Africa%2C%20MDD%20is%20associated%20with%20increased%20mortality.%20We%20found%20that%20noncommunicable%20diseases%2C%20rather%20than%20infectious%20diseases%2C%20are%20important%20mediators%20of%20the%20effect%20of%20MDD%20on%20mortality.%22%2C%22date%22%3A%222025-01-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FEDE.0000000000001804%22%2C%22ISSN%22%3A%221531-5487%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22TCMBXKKM%22%5D%2C%22dateModified%22%3A%222025-03-10T15%3A57%3A45Z%22%7D%7D%2C%7B%22key%22%3A%222XD6TBKQ%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Samim%20et%20al.%22%2C%22parsedDate%22%3A%222025-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ESamim%2C%20Daryoush%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EMuula%2C%20Guy%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EBanholzer%2C%20Nicolas%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EChibomba%2C%20Douglas%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EXulu%2C%20Sihle%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282025%29.%20Cardiovascular%20Involvement%20in%20Tuberculosis%20Patients%20Treated%20in%20Southern%20Africa.%20%3Ci%3EJACC.%20Advances%3C%5C%2Fi%3E%2C%20%3Ci%3E4%3C%5C%2Fi%3E%20%281%29%2C%20S.%20101427.%20%3Ca%20class%3D%27zp-DOIURL%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jacadv.2024.101427%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jacadv.2024.101427%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Cardiovascular%20Involvement%20in%20Tuberculosis%20Patients%20Treated%20in%20Southern%20Africa.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daryoush%22%2C%22lastName%22%3A%22Samim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guy%22%2C%22lastName%22%3A%22Muula%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Banholzer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Douglas%22%2C%22lastName%22%3A%22Chibomba%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sihle%22%2C%22lastName%22%3A%22Xulu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carolyn%22%2C%22lastName%22%3A%22Bolton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denise%22%2C%22lastName%22%3A%22Evans%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lisa%22%2C%22lastName%22%3A%22Perrig%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefano%22%2C%22lastName%22%3A%22De%20Marchi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gunar%22%2C%22lastName%22%3A%22Gunther%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Egger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22Pilgrim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lukas%22%2C%22lastName%22%3A%22Fenner%22%7D%5D%2C%22abstractNote%22%3A%22Background%3A%20Tuberculosis%20%28TB%29%20is%20the%20leading%20cause%20of%20death%20among%20people%20with%20HIV%20and%20a%20major%20global%20health%20challenge.%20Subclinical%20cardiovascular%20manifestations%20of%20TB%20are%20poorly%20documented%20in%20high%20TB%20and%20HIV%20burden%20countries.%20Objectives%3A%20The%20purpose%20of%20this%20study%20was%20to%20quantify%20the%20prevalence%20of%20cardiovascular%20involvement%20in%20TB%20patients%20and%20investigate%20changes%20after%20completion%20of%20anti-TB%20treatment.%20Methods%3A%20HIV-positive%20and%20HIV-negative%20patients%20diagnosed%20with%20pulmonary%20TB%20between%20October%202022%20and%20November%202023%20were%20enrolled%20from%202%20tertiary%20care%20hospitals%20in%20Zambia%20and%20South%20Africa.%20Standardized%20transthoracic%20echocardiography%20%28TTE%29%20was%20conducted%20at%20TB%20diagnosis%20and%20after%206%20months%20of%20anti-TB%20treatment.%20Cross-%20sectional%20and%20longitudinal%20analyses%20assessed%20pericardial%20effusion%2C%20thickening%2C%20or%20calcification%2C%20with%20and%20without%20signs%20of%20pericardial%20constriction.%20Results%3A%20A%20total%20of%20286%20TB%20patients%20%28218%20%5B76%25%5D%20men%2C%20109%20%5B38%25%5D%20people%20with%20HIV%2C%20median%20age%2035%20years%29%20underwent%20TTE%20at%20TB%20diagnosis%2C%20of%20whom%20105%20participants%20had%20a%20second%20TTE%20after%20completion%20of%20treatment.%20At%20TB%20diagnosis%2C%20134%20%2847%25%29%20had%20pericardial%20effusions%2C%2086%20%2830%25%29%20thickening%2C%207%20%282%25%29%20calcifications%2C%20103%20%2842%25%29%20signs%20of%20constriction%2C%20and%2013%20%2812%25%29%20had%20definite%20diagnosis%20of%20constriction.%20After%20TB%20treatment%2C%20pericardial%20effusions%20%2847%25%20vs%2016%25%2C%20P%20%3C%200.001%29%20and%20pericardial%20thickenings%20%2830%25%20vs%2015%25%2C%20P%20%3D%200.002%29%20became%20less%20prevalent.%20Pericardial%20calcifications%20%282%25%20vs%201%25%2C%20P%20%3D%200.4%29%2C%20signs%20of%20constrictions%20%2842%25%20vs%2038%25%2C%20P%20%3D%200.4%29%2C%20and%20definite%20diagnosis%20of%20constriction%20%2812%25%20vs%2014%25%2C%20P%20%3D%200.8%29%20were%20similar.%20Conclusions%3A%20Cardiac%20involvement%20is%20frequent%20in%20newly%20diagnosed%20TB%20patients.%20Early%20pericardial%20changes%20may%20be%20reversed%20with%20anti-TB%20treatment.%20Echocardiographic%20screening%20facilitates%20early%20detection%20and%20timely%20management%20of%20cardiovascular%20involvement%20in%20TB%20patients.%22%2C%22date%22%3A%222025%20Jan%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jacadv.2024.101427%22%2C%22ISSN%22%3A%222772-963X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22NMNPNZRP%22%2C%22TCMBXKKM%22%5D%2C%22dateModified%22%3A%222025-03-10T15%3A56%3A42Z%22%7D%7D%2C%7B%22key%22%3A%22FG32B8TS%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Metekoua%20et%20al.%22%2C%22parsedDate%22%3A%222025%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EMetekoua%2C%20Carole%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ERuffieux%2C%20Yann%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EMwansa-Kambafwile%2C%20Judith%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EKellett%2C%20Peter%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EEgger%2C%20Matthias%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282025%29.%20Patterns%20of%20incident%20Burkitt%20lymphoma%20during%20the%20HIV%20epidemic%20among%20the%20Black%20African%20and%20White%20population%20in%20South%20Africa.%20%3Ci%3EBr%20J%20Cancer%3C%5C%2Fi%3E.%20%3Ca%20class%3D%27zp-DOIURL%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41416-024-02937-8%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41416-024-02937-8%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Patterns%20of%20incident%20Burkitt%20lymphoma%20during%20the%20HIV%20epidemic%20among%20the%20Black%20African%20and%20White%20population%20in%20South%20Africa%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carole%22%2C%22lastName%22%3A%22Metekoua%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yann%22%2C%22lastName%22%3A%22Ruffieux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Judith%22%2C%22lastName%22%3A%22Mwansa-Kambafwile%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Kellett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Egger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mazvita%22%2C%22lastName%22%3A%22Muchengeti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eliane%22%2C%22lastName%22%3A%22Rohner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tracey%22%2C%22lastName%22%3A%22Wiggill%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222025%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41416-024-02937-8%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22NMNPNZRP%22%2C%22TCMBXKKM%22%5D%2C%22dateModified%22%3A%222025-03-10T15%3A57%3A08Z%22%7D%7D%5D%7D
Schwab, Tiana C.; Joseph, Lavania; Moono, Andrew; Göller, Pauline C.; Motsei, Mamello et al. (2025). Field evaluation of nanopore targeted next-generation sequencing to predict drug-resistant tuberculosis from native sputum in South Africa and Zambia.
Journal of Clinical Microbiology,
63 (3), S. e0139024.
http://doi.org/10.1128/jcm.01390-24.
Chihota, Belinda Varaidzo; Mandiriri, Ardele; Muula, Guy; Banda, Esau; Shamu, Tinei et al. (2025). Cohort profile: Noncommunicable diseases and ideal cardiovascular health among people living with and without HIV in Zambia and Zimbabwe (NCDzz cohort).
BMJ Open,
15 (2), S. e088706.
http://doi.org/10.1136/bmjopen-2024-088706.
Anderson, Kim; Rabie, Helena; Eley, Brian S.; Frigati, Lisa; Nuttall, James et al. (2025). Mother-child dyads living with HIV in the Western Cape, South Africa: Undetectable = Undetectable?
Journal of the International AIDS Society,
28 (2), S. e26418.
http://doi.org/10.1002/jia2.26418.
Banholzer, Nicolas; Middelkoop, Keren; Leukes, Juane; Weingartner, Ernest; Schmutz, Remo et al. (2025). Estimating Mycobacterium tuberculosis transmission in a South African clinic: Spatiotemporal model based on person movements.
PLoS Computational Biology,
21 (2), S. e1012823.
http://doi.org/10.1371/journal.pcbi.1012823.
Ford, Nathan; Kassanjee, Reshma; Stelzle, Dominik; Jarvis, Joseph N.; Sued, Omar et al. (2025). Global prevalence of advanced HIV disease in healthcare settings: a rapid review.
Journal of the International AIDS Society,
28 (2), S. e26415.
http://doi.org/10.1002/jia2.26415.
Didden, Christiane; Egger, Matthias; Folb, Naomi; Maartens, Gary; Rohner, Eliane et al. (2025). The Contribution of Noncommunicable and Infectious Diseases to the Effect of Depression on Mortality: A Longitudinal Causal Mediation Analysis.
Epidemiology (Cambridge, Mass.),
36 (1), S. 88–98.
http://doi.org/10.1097/EDE.0000000000001804.
Samim, Daryoush; Muula, Guy; Banholzer, Nicolas; Chibomba, Douglas; Xulu, Sihle et al. (2025). Cardiovascular Involvement in Tuberculosis Patients Treated in Southern Africa.
JACC. Advances,
4 (1), S. 101427.
http://doi.org/10.1016/j.jacadv.2024.101427.
Metekoua, Carole; Ruffieux, Yann; Mwansa-Kambafwile, Judith; Kellett, Peter; Egger, Matthias et al. (2025). Patterns of incident Burkitt lymphoma during the HIV epidemic among the Black African and White population in South Africa.
Br J Cancer.
http://doi.org/10.1038/s41416-024-02937-8.